Healthcare
New Guide Aims to Bridge Business Knowledge Gap for Dental Practice Owners
A comprehensive new book by dental consultant Joseph Wineman provides essential operational guidance for dentists transitioning to practice ownership, addressing critical business challenges beyond clinical training.
MEDICLIN Reports Strong Nine-Month Performance with 41.7% Operating Profit Growth
MEDICLIN Aktiengesellschaft demonstrated robust financial performance in the first nine months of 2025, with group operating results surging 41.7% to €48.9 million and sales growing 5.1% to €586.9 million, signaling strong recovery in the healthcare sector despite ongoing cost pressures.
Soligenix Secures Financial Stability Through 2026 to Advance Rare Disease and Biodefense Pipeline
Soligenix has strengthened its financial position with strategic capital initiatives, providing runway through 2026 to advance multiple late-stage therapeutic and vaccine candidates addressing rare diseases and biodefense needs.
Club Pilates Launches National 'Every Body' Campaign to Promote Fitness Inclusivity
Club Pilates has launched its first national brand campaign featuring real members to challenge fitness stereotypes and promote accessibility across all body types and experience levels.
Lung Cancer Screening Rates Remain Critically Low Despite Improved Survival Outcomes
A new report reveals alarmingly low lung cancer screening rates in the U.S. despite recent survival improvements, highlighting a critical gap in early detection for the nation's deadliest cancer.
Kairos Pharma Reports Promising Phase 2 Results for Prostate Cancer Treatment ENV105
Kairos Pharma's ENV105 demonstrates 86% clinical benefit rate in advanced metastatic prostate cancer patients when combined with standard therapy, potentially addressing critical treatment resistance challenges in oncology.
Five Health Tech Finalists Compete to Advance Cardiovascular and Brain Health Solutions
The American Heart Association has selected five innovative health technology companies as finalists in its global competition, highlighting emerging solutions that could significantly impact the prevention and treatment of heart disease and stroke worldwide.
GeoVax to Report Q3 2025 Financial Results and Provide Business Update
GeoVax Labs will report its third quarter 2025 financial results and provide updates on its clinical-stage vaccine and immunotherapy programs, including COVID-19 vaccines for immunocompromised patients and oncology treatments.
Pacylex and Heidelberg Pharma Present Promising Zelenirstat ADC Data at World ADC Conference
Pacylex Pharmaceuticals and Heidelberg Pharma are presenting data showing zelenirstat's potential as a novel antibody drug conjugate payload, demonstrating significantly increased potency against breast and prostate cancer cells compared to oral administration alone.
American Heart Association Recognizes Three Digital Health Innovators in CarePlan Challenge
The American Heart Association has selected three health technology innovators for their digital solutions that integrate clinical guidelines to transform cardiovascular care delivery and improve patient outcomes.
Heights Wellness Retreat Expands to Porter Ranch with Holistic Approach
The opening of Heights Wellness Retreat in Porter Ranch represents a strategic expansion of wellness services in Southern California, offering both traditional and innovative touchless therapies to address growing consumer demand for holistic health solutions.
Heidelberg Pharma Reports Promising Clinical Data for Multiple Myeloma Treatment HDP-101
Heidelberg Pharma will present new clinical data showing objective responses and anti-tumor activity in multiple myeloma patients treated with its lead antibody-drug conjugate candidate HDP-101, highlighting its potential to address significant unmet medical needs in relapsed or refractory cases.
Thomas Meier Appointed as New CEO of Medios AG, Signaling Strategic Growth Phase
Medios AG appoints Thomas Meier as new CEO to drive expansion in the European Specialty Pharma market, bringing international leadership experience from Swiss CDMO Bachem Holding AG.
Sapu Nano Announces First Human Trial of Injectable Everolimus Formulation for Breast Cancer
Sapu Nano has revealed initial human clinical trials for Sapu-003, an intravenous formulation of Everolimus that could offer improved bioavailability and efficacy compared to oral versions for breast cancer treatment.
Soligenix Strengthens CTCL Advisory Board to Advance HyBryte Therapy Development
Soligenix has updated its U.S. Medical Advisory Board for cutaneous T-cell lymphoma to support the clinical advancement of HyBryte and related therapies, reflecting the company's strategic focus on navigating complex regulatory and commercialization challenges in the rare disease space.
American Heart Association Launches Initiative to Accelerate Aortic Stenosis Diagnosis and Clinical Trial Access
The American Heart Association has launched a new initiative to improve early diagnosis of aortic stenosis and increase participation in clinical trials, potentially transforming care for this serious heart condition that often goes undiagnosed until advanced stages.
NanoViricides to Present Broad-Spectrum Antiviral Pipeline at Spartan Capital Investor Conference
NanoViricides will present its clinical-stage antiviral drug pipeline at the Spartan Capital Investor Conference, highlighting the potential significance of its platform technology for treating multiple viral diseases including RSV, COVID-19, influenza, and other respiratory infections.
LogicMark CEO Outlines Growth Strategy Through Personal Safety Innovation
LogicMark CEO Chia-Lin Simmons discusses the company's SaaS model and innovation-driven growth strategy in the personal emergency response systems market, highlighting how technology is transforming safety solutions for at-risk populations.
LogicMark CEO Discusses Connected Care Platform for At-Risk Populations
LogicMark CEO Chia-Lin Simmons detailed the company's comprehensive medical safety device offerings for seniors across all care levels during a recent interview, highlighting the importance of connected care technology for vulnerable populations.
Cybin Secures $175 Million in Funding to Advance Mental Health Therapeutics
Cybin Inc. has closed a $175 million registered direct offering with top healthcare investors, providing critical capital to advance its Phase 3 clinical programs for novel mental health treatments addressing major depressive disorder and generalized anxiety disorder.
Cybin Chief Medical Officer to Present at Prestigious 2025 Milken Institute Health Summit
Cybin Inc.'s Chief Medical Officer will participate in the 2025 Milken Institute Future of Health Summit, highlighting the company's advanced clinical-stage mental health treatments and their potential to address significant unmet medical needs.
GeoVax Relocates Headquarters and Labs to Atlanta Area to Fuel Growth and Pipeline Advancement
GeoVax Labs is relocating its corporate headquarters and laboratory operations to new Atlanta-area facilities, positioning the clinical-stage biotechnology company for accelerated growth, late-stage development, and future commercialization of its cancer and infectious disease therapies.
Maryland Faces Health Insurance Challenges as Federal Tax Credits Expire and New Rules Take Effect
Maryland residents confront significant health insurance changes including premium increases due to expiring federal tax credits, new restrictions on DACA recipients, and upcoming enrollment deadline reductions that could impact coverage for hundreds of thousands of people.
Maryland Residents Face Potential Health Care Premium Hikes as Subsidy Deadline Nears
Over 180,000 Maryland residents could experience significant health care premium increases if Congress fails to extend enhanced Obamacare subsidies before Saturday's deadline.
ABVC BioPharma Reports 230% Licensing Revenue Growth and Major Asset Expansion in Q3 2025
ABVC BioPharma achieved significant financial growth with 230% year-over-year licensing revenue increase and 181% asset expansion, driven by strategic investments in Taiwan manufacturing facilities that strengthen the company's global dual-core operational structure.
Quick Bystander CPR Within Five Minutes Nearly Doubles Pediatric Cardiac Arrest Survival
New research shows that initiating CPR within five minutes of a child's cardiac arrest can nearly double survival rates, highlighting the critical importance of immediate bystander intervention for pediatric emergencies.
Optimal Cardiovascular Health May Offset Dementia Risk in Type 2 Diabetes Patients
New research suggests that maintaining optimal cardiovascular health through the American Heart Association's Life's Essential 8 metrics can significantly reduce the risk of cognitive decline and dementia in people with Type 2 diabetes, even for those with high genetic risk.
Hidden Atrial Dysfunction Identified as Stroke Risk Factor in Heart Muscle Disease Patients
A new study reveals that people with transthyretin amyloid cardiomyopathy face significantly higher stroke risk when they have atrial electromechanical dysfunction, and researchers have developed a noninvasive assessment tool to identify those who might benefit from preventive treatments.
Long-Term Melatonin Use Linked to Increased Heart Failure Risk in Insomnia Patients, Study Finds
A preliminary study suggests adults with insomnia who used melatonin supplements for at least one year had significantly higher rates of heart failure diagnosis, hospitalization and death compared to non-users, raising important safety concerns about the widely available sleep aid.
Combining Healthy Lifestyle Habits with GLP-1 Medications Reduces Cardiovascular Risk in Type 2 Diabetes Patients
A study of over 63,000 veterans with Type 2 diabetes found that combining GLP-1 receptor agonist medications with at least six healthy lifestyle habits reduced cardiovascular event risk by 50% compared to standard care alone.